James R. Berenson, MD, Inc.

On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest findings and … Article

Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, … Article

New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative

LOS ANGELES, Nov. 11, … Article